NRG
TEVA icon

Nemes Rush Group’s Teva Pharmaceuticals TEVA Stock Holding History

Nemes Rush Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12
Closed -$123 – 686
2023
Q3 		$123 Buy
+12
New +$123 ﹤0.01% 637